関連する実験動画
Updated: Jun 24, 2026
04:24
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
慢性心不全患者の運動トレーニングの効果と安全性:HF-ACTIONランダム化対照試験
Christopher M O'Connor1, David J Whellan, Kerry L Lee
1Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA. oconn002@mc.duke.edu
JAMA
|April 9, 2009
まとめ
運動トレーニングは,初回分析では,心不全患者の死亡率や入院率に有意な減少を示さなかった. しかし,調整された分析では,運動による死亡率と入院率の減少において,軽微な有意な利点があることが明らかになった.
科学分野:
- 心臓病学 心臓病学
- 運動生理学 運動生理学
- クリニック・トライアル 臨床試験
背景:
- ガイドラインは,安定した心不全の患者に対して,運動トレーニングを推奨しています.
- 以前の研究では,運動トレーニングが臨床結果に与える影響を評価する力がなかった.
研究 の 目的:
- 心不全患者の運動トレーニングの有効性と安全性を評価する.
- 運動訓練が死亡率と入院率に影響を与えるかどうかを判断する.
主な方法:
- 2331人の心不全患者が参加した多センターランダム化対照試験 (HF-ACTION).
- 介入グループは通常のケアとエアロビック運動トレーニングを受け,対照群は通常のケアのみを受けました.
- 主要エンドポイント:全原因死亡率または入院の複合;二次エンドポイント:死亡率および入院のサブタイプ.
主要な成果:
- 主要分析では,全因死亡率または入院率の非有意な減少を示した (HR,0.93;P=.13).
- また,二次エンドポイントは,プライマリ分析では非有意な減少を示した.
- 調整した分析により,全因死亡率または入院率 (HR,0.89;P=.03) と心血管疾患死亡率またはHF入院率 (HR,0.85;P=.03) の有意な控えめな減少が明らかになった.
結論:
- 議定書に規定された一次分析では,運動トレーニングが死亡率や入院率に有意な影響を与えないことが示された.
- 調整された分析によると,運動トレーニングは,心不全患者の特定の臨床結果に対して,控えめな有意な利点を提供することが示唆されています.
- 副作用は,運動と通常のケアグループの間で類似していました.
関連する概念動画
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:20Exercise and Cardiovascular Response
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:22Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...